Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand?

被引:0
|
作者
Goto, Yusuke [1 ]
机构
[1] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
关键词
D O I
10.1111/iju.15167
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:445 / 446
页数:2
相关论文
共 50 条
  • [1] Stereotactic body radiation therapy for kidney cancer. Where do we stand?
    Sosa-Fajardo, Paloma
    Blanco-Suarez, Jesus M.
    Pineda-Munguia, Alvaro
    Rubi-Olea, Luz
    Peleteiro-Higuero, Paula
    Gajate, Pablo
    Zafra-Martin, Juan
    Siva, Shankar
    Bossi, Alberto
    Lopez-Campos, Fernando
    Counago, Felipe
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (05) : 437 - 445
  • [2] Stereotactic Body Radiation Therapy in Recurrent Head and Neck Cancer: Where Do We Stand?
    Nath, Jyotiman
    Neog, Moniprom
    Bhattacharyya, Mouchumee
    Kalita, Apurba Kumar
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, 76 (2) : 2212 - 2215
  • [3] Stereotactic Body Radiation Therapy in Recurrent Head and Neck Cancer: Where Do We Stand?
    Jyotiman Nath
    Moniprom Neog
    Mouchumee Bhattacharyya
    Apurba Kumar Kalita
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2024, 76 : 2212 - 2215
  • [4] The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?
    Mohamad, Issa
    Karam, Irene
    El-Sehemy, Ahmed
    Abu-Gheida, Ibrahim
    Al-Ibraheem, Akram
    AL-Assaf, Hossam
    Aldehaim, Mohammed
    Alghamdi, Majed
    Alotain, Ibrahim
    Ashour, May
    Bushehri, Ahmad
    ElHaddad, Mostafa
    Hosni, Ali
    CANCERS, 2023, 15 (20)
  • [5] Postoperative radiation therapy for lung cancer: Where do we stand?
    Kelsey, Chris R.
    Marks, Lawrence B.
    Wilson, Lynn D.
    ONCOLOGY-NEW YORK, 2008, 22 (03): : 301 - 310
  • [6] Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand?'
    Holmdahl, Rikard
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10)
  • [7] The genetic patterns of bladder cancer. Where do we stand now?
    Salagierski, Maciej
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2013, 66 (04) : 411 - 412
  • [8] Particle therapy in lung cancer: Where do we stand?
    Pijls-Johannesmata, Madelon
    Grutters, Janneke P. C.
    Lambin, Philippe
    De Ruysscher, Dirk
    CANCER TREATMENT REVIEWS, 2008, 34 (03) : 259 - 267
  • [9] Consolidation therapy in ovarian cancer: Where do we stand?
    Dearnley, Daynelle D.
    McMeekin, D. Scott
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (01) : 3 - 7
  • [10] Gene therapy for thyroid cancer: Where do we stand?
    DeGroot, LJ
    Zhang, RS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07): : 2923 - 2928